Organic Letters
Letter
authors would like to thank Rashad Karimov at MSKCC,
Molecular Pharmacology and Chemistry Program for his
suggestions and critically reading this manuscript. The authors
wish to thank George Sukenick and Rong Wang of the NMR
Analytical Core Facility at MSKCC for their assistance with
NMR and MS instruments and experiments. We thank the
NYU Molecular Design Institute for the purchase of the Bruker
SMART APEXII Diffractometer.
REFERENCES
■
(1) Hulme, C.; Gore, V. Curr. Med. Chem. 2003, 10, 51.
(2) Dolle, R. E.; Le Bourdonnec, B.; Goodman, A. J.; Morales, G. A.;
Thomas, C. J.; Zhang, W. J. Comb. Chem. 2008, 10, 753.
(3) (a) Domling, A.; Wang, W.; Wang, K. Chem. Rev. 2012, 112,
̈
3083. (b) Domling, A.; Ugi, I. Angew. Chem., Int. Ed. 2000, 39, 3168.
̈
(4) (a) Chandrasekharappa, A. P.; Badiger, S. E.; Dubey, P. K.;
Panigrahi, S. K.; Manukonda, S. R. Bioorg. Med. Chem. Lett. 2013, 23,
2579. (b) Ulhaq, S.; Chinje, E. C.; Naylor, M. A.; Jaffar, M.; Stratford,
I. J.; Threadgill, M. D. Bioorg. Med. Chem. 1999, 7, 1787. (c) Horton,
D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893.
(d) Hayashi, S.; Hirao, A.; Imai, A.; Nakamura, H.; Murata, Y.; Ohashi,
K.; Nakata, E. J. Med. Chem. 2009, 52, 610. (e) Siracusa, M. A.;
Salerno, L.; Modica, M. N.; Pittala, V.; Romeo, G.; Amato, M. E.;
̀
Nowak, M.; Bojarski, A. J.; Mereghetti, I.; Cagnotto, A.; Mennini, T. J.
Med. Chem. 2008, 51, 4529.
Figure 2. Diversification of the novel benzoxazole scaffold 1.
countless other derivatives well beyond the scope of the present
publication (amines, amides, tetrazoles, halogens).
(5) Kumar, R. V. Asian J. Chem. 2004, 16, 1241.
(6) (a) Ruijter, E.; Scheffelaar, R.; Orru, R. V. A. Angew. Chem., Int.
Ed. 2011, 50, 6234. (b) Sunderhaus, J. D.; Dockendorff, C.; Martin, S.
F. Org. Lett. 2007, 9, 4223. (c) Tempest, P.; Ma, V.; Thomas, S.; Hua,
Z.; Kelly, M. G.; Hulme, C. Tetrahedron Lett. 2001, 42, 4959.
(7) (a) Boissarie, P. J.; Hamilton, Z. E.; Lang, S.; Murphy, J. A.;
Suckling, C. J. Org. Lett. 2011, 13, 6256. (b) Spatz, J. H.; Bach, T.;
Umkehrer, M.; Bardin, J.; Ross, G.; Burdack, C.; Kolb, J. Tetrahedron
Lett. 2007, 48, 9030.
(8) (a) El Kaim, L.; Grimaud, L. Tetrahedron 2009, 65, 2153.
(b) Vlaar, T.; Ruijter, E.; Maes, B. U. W.; Orru, R. V. A. Angew. Chem.,
Int. Ed. 2013, 52, 7084.
́
(9) (a) Bienayme, H.; Bouzid, K. Angew. Chem., Int. Ed. 1998, 37,
2234. (b) Bonne, D.; Dekhane, M.; Zhu, J. Org. Lett. 2005, 7, 5285.
(c) Faggi, C.; García-Valverde, M. a.; Marcaccini, S.; Menchi, G. Org.
In summary, we discovered a convenient, triflic acid
catalyzed, isocyanide-based heterocycle-forming three-compo-
nent reaction between 2-aminophenols, isocyanides, and
ketones that leads to benzoxazoles and other heterocycles.
The reaction progresses via a benzoxazine intermediate formed
by intramolecular nucleophilic trapping of the reactive nitrilium
intermediate by an adjacent phenolic group. Previous literature
examples of nitrilium trapping yielded stable products, whereas
in our case the trapped intermediates could be opened up by
bis-nucleophiles. The reactivity of benzoxazine to bis-
nucleophiles was leveraged to synthesize an array of
heterocyclic scaffolds including benzimidazoles, dihydrothia-
zoles, and benzothiazoles. The reaction showed good functional
group tolerance and is compatible with different ketones and
aminophenols, ideal for the generation of molecule libraries
under mild reaction conditions. The reactivity of the phenolic
hydroxyl and the aromatic secondary amine was further
exploited to diversify the scaffolds. Our future studies will
focus on investigating and controlling the stereoselectivity of
this reaction pathway.
Lett. 2010, 12, 788. (d) Franckevici
R. M.; Ley, S. V. Synthesis 2006, 19, 3215. (e) García-Gonzal
Gonzalez-Zamora, E.; Santillan, R.; Domínguez, O.; Mendez-Stivalet, J.
M.; Farfan, N. Tetrahedron 2009, 65, 5337. (f) Groebke, K.; Weber, L.;
̌
us, V.; Longbottom, D. A.; Turner,
́
ez, M. C.;
́
́
́
Mehlin, F. Synlett 1998, 6, 661. (g) Hashimoto, T.; Kimura, H.;
Kawamata, Y.; Maruoka, K. Angew. Chem., Int. Ed. 2012, 51, 7279.
(h) Heravi, M.; Baghernejad, B.; Oskooie, H. Mol. Divers. 2009, 13,
395. (i) Krasavin, M.; Parchinsky, V. Synlett 2008, 5, 645. (j) Kysil, V.;
Tkachenko, S.; Khvat, A.; Williams, C.; Tsirulnikov, S.; Churakova, M.;
Ivachtchenko, A. Tetrahedron Lett. 2007, 48, 6239. (k) Lei, C.-H.;
Wang, D.-X.; Zhao, L.; Zhu, J.; Wang, M.-X. J. Am. Chem. Soc. 2013,
135, 4708. (l) Shaabani, A.; Maleki, A.; Mofakham, H.; Khavasi, H. R.
J. Comb. Chem. 2008, 10, 323. (m) Shaabani, A.; Maleki, A.; Moghimi-
Rad, J. J. Org. Chem. 2007, 72, 6309. (n) Soeta, T.; Tamura, K.; Ukaji,
Y. Org. Lett. 2012, 14, 1226.
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental details and spectroscopic data. This material is
(10) (a) Dai, W.-M.; Li, H. Tetrahedron 2007, 63, 12866.
(b) Okandeji, B. O.; Gordon, J. R.; Sello, J. K. J. Org. Chem. 2008,
73, 5595.
(11) Poupaert, J.; Carato, P.; Colacino, E.; Yous, S. Curr. Med. Chem.
2005, 12, 877.
(12) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.
(13) Hartwig, J. F. Angew. Chem., Int. Ed. 1998, 37, 2046.
(14) Del Poeta, M.; Schell, W. A.; Dykstra, C. C.; Jones, S. K.;
Tidwell, R. R.; Kumar, A.; Boykin, D. W.; Perfect, J. R. Antimicrob.
Agents Chemother. 1998, 42, 2503.
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work is supported by research grants from the National
Institute of Drug Abuse to S.M. (DA034106-01) and G.W.P.
(DA06241, DA02165, and DA07242) and a core grant from
the National Cancer Institute to MSKCC (CA08748). The
(15) Kubota, H.; Rice, K. C. Tetrahedron Lett. 1998, 39, 2907.
D
dx.doi.org/10.1021/ol500328t | Org. Lett. XXXX, XXX, XXX−XXX